Cargando…

Age and Alzheimer’s Disease

Detalles Bibliográficos
Autor principal:	Meunier, Bernard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4924213/ https://www.ncbi.nlm.nih.gov/pubmed/27322314 http://dx.doi.org/10.3390/nu8060372

Ejemplares similares

Alzheimer's disease and aluminum toxicology.
por: Corain, B, et al.
Publicado: (1990)

Plasma tau levels in Alzheimer's disease
por: Zetterberg, Henrik, et al.
Publicado: (2013)

Catastrophe and Alzheimer's Disease
por: Larner, Andrew J
Publicado: (1995)

Association between dental amalgam fillings and Alzheimer’s disease
por: Zarghami, Amin, et al.
Publicado: (2016)

Analyzing Facial and Eye Movements to Screen for Alzheimer’s Disease
por: Nam, Uiseo, et al.
Publicado: (2020)

Vascular and Alzheimer Disease in Dementia
por: Strandberg, Timo E., et al.
Publicado: (2020)

Factors for Prevention of Alzheimer's Disease
por: Ivanova, Stefka, et al.
Publicado: (2023)

Systematic review of the association between Alzheimer’s disease and chronic glaucoma
por: Janssen, Sarah F, et al.
Publicado: (2015)

Measurement to improve care and outcomes for persons with Alzheimer's disease and dementia
por: Zimmerman, Sheryl, et al.
Publicado: (2022)

Alzheimer’s Disease: A Major Challenge in the Effective Treatment of Depression in the Elderly
por: Kapoor, Shailendra
Publicado: (2008)

Importance of hypoglycemia on the risk of Alzheimer’s disease in elderly subjects with diabetes mellitus
por: Muratli, Sevilay, et al.
Publicado: (2015)

No association between antiviral treatment and risk of Alzheimer's disease in German outpatients
por: Kostev, Karel, et al.
Publicado: (2021)

The potential impact of clinical factors on blood-based biomarkers for Alzheimer’s disease
por: Pan, Fengfeng, et al.
Publicado: (2023)

Drug therapies and presence of coronary artery disease may affect aortic stiffness in Alzheimer’s disease
por: Bektaş, Osman, et al.
Publicado: (2015)

Use of exaggerated language in news stories to describe drugs for treatment of Alzheimer's disease
por: Heigle, Benjamin, et al.
Publicado: (2020)

Reply to Peng and Zhao: Loss of endocytic protein TOM1 in Alzheimer’s disease
por: Martini, Alessandra C., et al.
Publicado: (2020)

Questioning the evidence for a Janus-faced nature of adult neurogenesis in Alzheimer’s disease
por: Phan, Trongha, et al.
Publicado: (2021)

Disease severity and minimal clinically important differences in clinical outcome assessments for Alzheimer's disease clinical trials
por: Van Dyck, Christopher H., et al.
Publicado: (2023)

Better understanding of ICI-induced cholangitis for better management
por: Meunier, Lucy, et al.
Publicado: (2023)

Low Levels of Triiodothyronine in Patients with Alzheimer’s Disease
por: Karimi, Fariba, et al.
Publicado: (2011)

Primary Prevention of Alzheimer’s Disease in Developing Countries
por: Kavoor, Anjana Rao, et al.
Publicado: (2015)

Pharmacological aspects of galantamine for the treatment of Alzheimer's disease
por: Kim, Jae Kwang, et al.
Publicado: (2017)

Magnesium may be an effective therapy for Alzheimer’s disease
por: Lei, Dao-Yun, et al.
Publicado: (2022)

Handgrip Strength in Elderly People with Alzheimer's Disease
por: Leandro-Merhi, Vania Aparecida, et al.
Publicado: (2023)

Reply: Unblinding in the lecanemab trial in Alzheimer’s disease
por: Hardy, John, et al.
Publicado: (2023)

Anti-amyloid therapies work for Alzheimer’s disease
por: Hardy, John
Publicado: (2023)

Lecanemab: A hope in the management of Alzheimer’s disease
por: Thakkar, Nandita, et al.
Publicado: (2023)

Letter to the Editor: Relationship Between Neuropsychiatric Symptoms and Activities of Daily Living in Alzheimer Disease
por: Yi, San Hak, et al.
Publicado: (2018)

Response to questioning the evidence for a Janus-faced nature of adult neurogenesis in Alzheimer's disease
por: Zhang, Xiaoqing, et al.
Publicado: (2021)

Response to Alzheimer’s research paper
por: Tait, H Mina
Publicado: (2013)

The age factor in Alzheimer’s disease
por: Guerreiro, Rita, et al.
Publicado: (2015)

T cell aging and Alzheimer’s disease
por: Guo, Lin, et al.
Publicado: (2023)

Cerebrovascular disease in ageing and Alzheimer’s disease
por: Love, Seth, et al.
Publicado: (2015)

Disease spread in age structured populations with maternal age effects
por: Clark, Jessica, et al.
Publicado: (2017)

Hypoperfusion, Mitochondria Failure, Oxidative Stress, and Alzheimer Disease
por: Aliev, Gjumrakch, et al.
Publicado: (2003)

New pathogenic variations of mitochondrial DNA in Alzheimer disease!!
por: Nia, Samira Sheibani, et al.
Publicado: (2013)

Tau protein as a target for Alzheimer’s disease management
por: Abdalla, Ahmed
Publicado: (2015)

Neuropsychiatric profiles in patients with Alzheimer's disease and vascular dementia
por: Raina, Sunil Kumar
Publicado: (2015)

Early and late-onset Alzheimer's disease: What are the differences?
por: Awada, Adnan A.
Publicado: (2015)

Flavonoids for treatment of Alzheimer's disease: An up to date review
por: Kim, Jae Kwang, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4je3km9e9dpnd1g51r1qfprmom